The authors showed that the expression of TGF-β is inversely proportional to the expression of MCP-1 in the early stages and is directly proportional to the expression of MCP-1 in the late stages of breast cancer, therefore, TGF-β promotes tumor progression in the late stages of breast cancer. Here, CCL2 is linked to breast cancer.